Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo library.
Key information
Latest press releases
- Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine
- GSK announces independent Consumer Healthcare company is to be called Haleon
- GSK announces additional purchase agreements with the Government of Canada for COVID-19 monoclonal antibody therapy, Sotrovimab
- GSK’s JEMPERLI (dostarlimab for injection) approved in Canada as an anti-PD-1 therapy for recurrent or advanced endometrial cancer
Media contacts
If you are a member of the Canadian media and you require more information from GlaxoSmithKline Inc., please contact Corporate Communications at 905-819-3363.
The telephone number above is for media enquiries only. To contact the Mississauga office switchboard, please call 905-819-3000 or visit our Contact Us page on this site.
-
GSK in Canada
GSK has a history in Canada that dates back to 1902
-
Our prescription medicines
Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the most common acute and chronic diseases
-
Our vaccines
Our vaccines business develops, produces and distributes around 2 million vaccines every day to people across over 160 countries
-
Our consumer healthcare products
When experiencing discomforts like sensitive teeth, colds and flu or joint pain, our everyday healthcare products will help you enjoy again.
